Year Founded: 1984
Number of Employees: 1092 as of 8th Dec ‘ 16
Approximate Annual Revenues: 525 crores (FY2016)
Key Personnel: Dr. D. R. Rao, Chairman and Managing
Director; D Sucheth Rao, Vice Chairman and CEO; D Saharsh
Rao, Joint Managing Director; Dr. M K Anwer, Vice President
– Research & Development; Dr. P Ravi, President – Technical;
Ogino Yasukazu, President, Neuland Laboratories K.K. (Japan);
Shashank Mahashabde, President – CMS, Neuland
Laboratories, Inc (USA)
Neuland’s technical and scientific teams help facilitate and
accelerate drug development for pharmaceutical companies. We
are a leader in cGMP manufacturing of active pharmaceutical
ingredients (APIs) and provide end-to-end chemistry-related
services for the pharma industry. For more than 30 years, we have
been focused on maintaining our customers’ competitiveness
with speed, efficiency and regulatory excellence.
Neuland’s two US FDA and EU GMP-compliant manufacturing
facilities have a capacity of 480 KL and produce more than 75
APIs across 10 diverse therapeutic areas. Our facilities are
routinely inspected and approved by the FDA, EDQM, PMDA
and other leading regulatory agencies.
Neuland is a chemistry solutions provider for the pharmaceutical
industry, including API manufacturing and synthesis of NCEs
and intermediates from clinical through commercial scale.
Working with over 700 customers in 80 countries, Neuland
manufactures APIs through its cGMP manufacturing facilities.
Nearly all products are produced for markets in Europe, the
U.S. and Japan. Neuland has developed 300+ processes, and
has filed 45 DMFs with the FDA and over 400 DMFs with health
authorities in Europe, Canada, Japan, Korea and Australia.
Generic Drug Substances (GDS)
Our core business & operational expertise is manufacturing APIs.
We are a preferred source for the pharmaceutical industry due
to API quality, our experience with niche chemistry, on-time
delivery performance and regulatory excellence.
Custom Manufacturing Solutions (CMS)
Neuland leverages proven expertise in chemical process
development and manufacturing to help clients accelerate drug
development and commercialization.
Peptide Synthesis Services
Neuland supplies high quality Peptide building blocks such as
Pseudoproline Dipeptides and other complex Fmoc building
blocks. Our services include peptide production from milligram
to multi-kilogram scale by standard sequential chemical peptide
synthesis & segment condensation strategies.